Skip to content

Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain

Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07035119
Enrollment
50
Registered
2025-06-24
Start date
2026-09-30
Completion date
2030-04-01
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scrotal Pain

Keywords

Scrotal pain, testicular pain, Transcranial magnetic stimulation

Brief summary

The purpose of this study is to perform an open label feasibility trial of TMS for the treatment of chronic scrotal content pain.

Detailed description

The purpose of this study is to perform an open label feasibility trial of TMS for the treatment of chronic scrotal content pain. Participants will be screened by study staff for contraindications to TMS treatment. TMS will be delivered use the MagVenture TMS machine. TMS will be delivered during 15 minutes per session, 3 sessions each day, for 3 days. A custom developed SMS text EMA system will be used to gather daily data on pain and functioning in study participants.

Interventions

OTHERTranscranial magnetic stimulation

Resting motor threshold will be established by first finding the area of the motor cortex associated with visible twitch of the right abductor pollicis brevis (APB). Parameter Estimation by Sequential Testing (PEST) will be conducted to quantify resting motor threshold using visible APB twitch. The left dorsolateral prefrontal cortex (DLPFC) will be located using the Beam F3 method and marked with a felt-tipped marker on the scalp. TMS will be delivered over left DLPFC at 110% of resting motor threshold at 10Hz (5-seconds-on; 10-seconds-off) for 15 minutes per session (3000 pulses), 3 sessions each day (30-minute rest in-between sessions), for 3 days (within 5 consecutive days; a total of 27,000 pulses).

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male patients with chronic scrotal pain lasting for 6 or more months. * Pain must be present 3 or more days of the week.

Exclusion criteria

* No new pain medications within the last 30 days.

Design outcomes

Primary

MeasureTime frameDescription
Patient reported pain score on SMS text EMA systembaseline, and post intervention (0 days, 1 week, 2 weeks, 1 month, 3 months, 6 months)A custom developed SMS text EMA system will be used to gather daily data on pain

Secondary

MeasureTime frameDescription
Patient reported post procedure quality of life as measured on an SMS text EMA systembaseline, and post intervention (0 days, 1 week, 2 weeks, 1 month, 3 months, 6 months)A custom developed SMS text EMA system will be used to gather daily data on pain
Progression to other treatmentsWithin 6 months after completionProgression to other medical or surgical treatments

Countries

United States

Contacts

CONTACTSolomon Hayon, MD
hayon@musc.edu18437927888
STUDY_DIRECTORJeffery Brockardt, Ph.D.

Medical University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026